Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential

1 Jan 1999

Abstract excerpt

The rabies virus glycoprotein molecule (G) can be divided into two parts separated by a flexible hinge: the NH2 half (site II part) containing antigenic site II up to the linear region (amino acids [aa] 253 to 275 encompassing epitope VI [aa 264]) and the COOH half (site III part) containing antigenic site III and the transmembrane and cytoplasmic domains. The structural and immunological roles of each part were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microbial infections and disease research
Share to Rabies epidemiology and control
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9847325
DOI: 10.1128/jvi.73.1.225-233.1999

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chimeric Lyssavirus Glycoproteins with Increased Immunological PotentialPMID 9847325Read ↗

Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?Semantic proximity Read ↗

Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.Semantic proximity Read ↗

Evidence of Two<i>Lyssavirus</i>Phylogroups with Distinct Pathogenicity and ImmunogenicitySemantic proximity Read ↗

An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteinsSemantic proximity Read ↗

Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.Semantic proximity Read ↗

Research Advances on the Interactions between Rabies Virus Structural Proteins and Host Target Cells: Accrued Knowledge from the Application of Reverse Genetics SystemsSemantic proximity Read ↗

Immunogenicity and Safety of Recombinant Rabies Viruses Used for Oral Vaccination of Stray Dogs and WildlifeSemantic proximity Read ↗

A Recombinant Rabies Virus Encoding Two Copies of the Glycoprotein Gene Confers Protection in Dogs against a Virulent ChallengeSemantic proximity Read ↗

Epitope-Based Peptide Vaccine Design against Mokola Rabies Virus Glycoprotein G Utilizing In Silico ApproachesSemantic proximity Read ↗

Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 LyssavirusesSemantic proximity Read ↗

Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly ImmunogenicSemantic proximity Read ↗

Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis VirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.